1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole (Imazalil)

CAS35554-44-0
EC252-615-0

List details

Active substance data

Substance information page external link [echa.europa.eu]
Product type PT03-Veterinary hygiene
BAS number 1317
Candidate for substitution Under Assessment
Regulatory Process
  • Review programme substance
Assesment status Initial application for approval in progress
Assesment sub-status Notified

Approval data

Evaluating competent authority
  • Germany

Other data

Related authorised biocidal products 0
Factsheet URL external link [echa.europa.eu]
RML Id 100.047.817
Inclusion category 0

Related substances

By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.

Related regulatory records

  • Registry of CLH intentions until outcome under the name 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
    Deadline for commenting: 2012-10-05
  • Harmonised classification and labelling (CLP Annex VI) under the name imazalil (ISO); 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
    Hazard Class and Category Codes: Carc. 2: Carcinogenicity; Acute Tox. 3: Acute toxicity; Acute Tox. 4: Acute toxicity; Eye Dam. 1: Serious eye damage/eye irritation; Aquatic Chronic 1: Hazardous to the aquatic environment

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

This version
July 5, 2019
  • Approval status: Cancelled application
  • Assesment status: Initial application for approval in progress
  • Assesment sub-status: Notified
June 25, 2019
  • Assesment status: Initial approval in progress
  • Assesment sub-status: Notified
  • Approval status: Cancelled application
Add the related substance to your watchlist to monitor this regulatory record.